PolyPid Ltd. (PYPD)
NASDAQ·Healthcare·Biotechnology
$4.51
+3.44%
Mkt Cap $42.60M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$9.50
Range $9.00 – $10.00
Implied Upside
+110.6%
Consensus $9.50 vs current $4.51
NASDAQ·Healthcare·Biotechnology
$4.51
+3.44%
Mkt Cap $42.60M
No recent rating data.
Price Target (2 analysts)
$9.50
Range $9.00 – $10.00
+110.6%
Consensus $9.50 vs current $4.51